Global Recombinant Glycosylated Protein Industry Research Report 2020, Forecast to 2025

September 2020 | 101 pages | ID: G78E3B0166E9EN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Recombinant Glycosylated Protein market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Recombinant Glycosylated Protein is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Recombinant Glycosylated Protein industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Recombinant Glycosylated Protein by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Recombinant Glycosylated Protein market are discussed.

The market is segmented by types:

• Insulin
• rHGH
• Interferon

It can be also divided by applications:

• Blood & Oncology Diseases
• Chronic Diseases
• Others

And this report covers the historical situation, present status and the future prospects of the global Recombinant Glycosylated Protein market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• Novartis International AG
• Biocon Limited
• Hospira Inc
• Celltrion Pharma Inc
• Teva Pharmaceutical Industries Ltd

Report Includes:

• xx data tables and xx additional tables
• An overview of global Recombinant Glycosylated Protein market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Recombinant Glycosylated Protein market
• Profiles of major players in the industry, including Novartis International AG, Biocon Limited, Hospira Inc, Celltrion Pharma Inc, Teva Pharmaceutical Industries Ltd.....

Research Objectives

• To study and analyze the global Recombinant Glycosylated Protein consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Recombinant Glycosylated Protein market by identifying its various subsegments.
• Focuses on the key global Recombinant Glycosylated Protein manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Recombinant Glycosylated Protein with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Recombinant Glycosylated Protein submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Recombinant Glycosylated Protein Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Recombinant Glycosylated Protein Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 RECOMBINANT GLYCOSYLATED PROTEIN INDUSTRY OVERVIEW

2.1 Global Recombinant Glycosylated Protein Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Recombinant Glycosylated Protein Global Import Market Analysis
  2.1.2 Recombinant Glycosylated Protein Global Export Market Analysis
  2.1.3 Recombinant Glycosylated Protein Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Insulin
  2.2.2 rHGH
  2.2.3 Interferon
2.3 Market Analysis by Application
  2.3.1 Blood & Oncology Diseases
  2.3.2 Chronic Diseases
  2.3.3 Others
2.4 Global Recombinant Glycosylated Protein Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Recombinant Glycosylated Protein Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Recombinant Glycosylated Protein Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Recombinant Glycosylated Protein Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Recombinant Glycosylated Protein Manufacturer Market Share
  2.4.5 Top 10 Recombinant Glycosylated Protein Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Recombinant Glycosylated Protein Market
  2.4.7 Key Manufacturers Recombinant Glycosylated Protein Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Recombinant Glycosylated Protein Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Recombinant Glycosylated Protein Industry Impact
  2.7.1 How the Covid-19 is Affecting the Recombinant Glycosylated Protein Industry
  2.7.2 Recombinant Glycosylated Protein Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Recombinant Glycosylated Protein Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Recombinant Glycosylated Protein Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL RECOMBINANT GLYCOSYLATED PROTEIN MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Recombinant Glycosylated Protein Sales Market Share by Region
4.2 Global Recombinant Glycosylated Protein Revenue Market Share by Region (2015-2019)
4.3 Global Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Recombinant Glycosylated Protein Market Size Detail
  4.4.1 North America Recombinant Glycosylated Protein Sales Growth Rate (2015-2020)
  4.4.2 North America Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Recombinant Glycosylated Protein Market Size Detail
  4.5.1 Europe Recombinant Glycosylated Protein Sales Growth Rate (2015-2020)
  4.5.2 Europe Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Recombinant Glycosylated Protein Market Size Detail
  4.6.1 Japan Recombinant Glycosylated Protein Sales Growth Rate (2015-2020)
  4.6.2 Japan Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Recombinant Glycosylated Protein Market Size Detail
  4.7.1 China Recombinant Glycosylated Protein Sales Growth Rate (2015-2020)
  4.7.2 China Recombinant Glycosylated Protein Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL RECOMBINANT GLYCOSYLATED PROTEIN MARKET SEGMENT BY TYPE

5.1 Global Recombinant Glycosylated Protein Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Recombinant Glycosylated Protein Sales and Market Share by Type (2015-2020)
  5.1.2 Global Recombinant Glycosylated Protein Revenue and Market Share by Type (2015-2020)
5.2 Insulin Sales Growth Rate and Price
  5.2.1 Global Insulin Sales Growth Rate (2015-2020)
  5.2.2 Global Insulin Price (2015-2020)
5.3 rHGH Sales Growth Rate and Price
  5.3.1 Global rHGH Sales Growth Rate (2015-2020)
  5.3.2 Global rHGH Price (2015-2020)
5.4 Interferon Sales Growth Rate and Price
  5.4.1 Global Interferon Sales Growth Rate (2015-2020)
  5.4.2 Global Interferon Price (2015-2020)

6 GLOBAL RECOMBINANT GLYCOSYLATED PROTEIN MARKET SEGMENT BY APPLICATION

6.1 Global Recombinant Glycosylated ProteinSales Market Share by Application (2015-2020)
6.2 Blood & Oncology Diseases Sales Growth Rate (2015-2020)
6.3 Chronic Diseases Sales Growth Rate (2015-2020)
6.4 Others Sales Growth Rate (2015-2020)

7 GLOBAL RECOMBINANT GLYCOSYLATED PROTEIN MARKET FORECAST

7.1 Global Recombinant Glycosylated Protein Sales, Revenue Forecast
  7.1.1 Global Recombinant Glycosylated Protein Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Recombinant Glycosylated Protein Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Recombinant Glycosylated Protein Price and Trend Forecast (2020-2025)
7.2 Global Recombinant Glycosylated Protein Sales Forecast by Region (2020-2025)
  7.2.1 North America Recombinant Glycosylated Protein Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Recombinant Glycosylated Protein Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Recombinant Glycosylated Protein Production, Revenue Forecast (2020-2025)
  7.2.4 China Recombinant Glycosylated Protein Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF RECOMBINANT GLYCOSYLATED PROTEIN INDUSTRY KEY MANUFACTURERS

8.1 Novartis International AG
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Novartis International AG Recombinant Glycosylated Protein Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Novartis International AG News
8.2 Biocon Limited
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Biocon Limited Recombinant Glycosylated Protein Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Biocon Limited News
8.3 Hospira Inc
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Hospira Inc Recombinant Glycosylated Protein Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Hospira Inc News
8.4 Celltrion Pharma Inc
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Celltrion Pharma Inc Recombinant Glycosylated Protein Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Celltrion Pharma Inc News
8.5 Teva Pharmaceutical Industries Ltd
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Teva Pharmaceutical Industries Ltd News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Recombinant Glycosylated Protein Picture
Figure Research Programs/Design for This Report
Figure Global Recombinant Glycosylated Protein Market by Regions (2019)
Table Global Market Recombinant Glycosylated Protein Comparison by Regions (M USD) 2019-2025
Table Global Recombinant Glycosylated Protein Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Recombinant Glycosylated Protein by Type in 2019
Figure Insulin Picture
Figure rHGH Picture
Figure Interferon Picture
Table Global Recombinant Glycosylated Protein Sales by Application (2019-2025)
Figure Global Recombinant Glycosylated Protein Sales Market Share by Application in 2019
Figure Blood & Oncology Diseases Picture
Figure Chronic Diseases Picture
Figure Others Picture
Table Global Recombinant Glycosylated Protein Sales by Manufacturer (2018-2020)
Figure Global Recombinant Glycosylated Protein Sales Market Share by Manufacturer in 2019
Table Global Recombinant Glycosylated Protein Revenue by Manufacturer (2018-2020)
Figure Global Recombinant Glycosylated Protein Revenue Market Share by Manufacturer in 2019
Table Global Recombinant Glycosylated Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Recombinant Glycosylated Protein Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Recombinant Glycosylated Protein Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Recombinant Glycosylated Protein Market
Table Key Manufacturers Recombinant Glycosylated Protein Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Glycosylated Protein
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Recombinant Glycosylated Protein Sales (K Units) by Region (2015-2020)
Table Global Recombinant Glycosylated Protein Sales Market Share by Region (2015-2019)
Figure Global Recombinant Glycosylated Protein Sales Market Share by Region (2015-2019)
Figure Global Recombinant Glycosylated Protein Sales Market Share by Region in 2018
Table Global Recombinant Glycosylated Protein Revenue (Million US$) by Region (2015-2020)
Table Global Recombinant Glycosylated Protein Revenue Market Share by Region (2015-2020)
Figure Global Recombinant Glycosylated Protein Revenue Market Share by Region (2015-2020)
Figure Global Recombinant Glycosylated Protein Revenue Market Share by Region in 2019
Table Global Recombinant Glycosylated Protein Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Recombinant Glycosylated Protein Sales (K Units) Growth Rate (2015-2020)
Table North America Recombinant Glycosylated Protein Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Recombinant Glycosylated Protein Sales (K Units) Growth Rate (2015-2020)
Table Europe Recombinant Glycosylated Protein Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Recombinant Glycosylated Protein Sales (K Units) Growth Rate (2015-2020)
Table Japan Recombinant Glycosylated Protein Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Recombinant Glycosylated Protein Sales (K Units) Growth Rate (2015-2020)
Table China Recombinant Glycosylated Protein Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Recombinant Glycosylated Protein Sales by Type (2015-2020)
Table Global Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Figure Global Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Table Global Recombinant Glycosylated Protein Revenue by Type (2015-2020)
Table Global Recombinant Glycosylated Protein Revenue Market Share by Type (2015-2020)
Figure Global Recombinant Glycosylated Protein Revenue Market Share by Type in 2019
Figure Global Insulin Sales Growth Rate (2015-2020)
Figure Global Insulin Price (2015-2020)
Figure Global rHGH Sales Growth Rate (2015-2020)
Figure Global rHGH Price (2015-2020)
Figure Global Interferon Sales Growth Rate (2015-2020)
Figure Global Interferon Price (2015-2020)
Table Global Recombinant Glycosylated Protein Sales by Application (2015-2020)
Table Global Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Figure Global Recombinant Glycosylated Protein Sales Market Share by Application in 2019
Figure Global Blood & Oncology Diseases Sales Growth Rate (2015-2020)
Figure Global Chronic Diseases Sales Growth Rate (2015-2020)
Figure Global Others Sales Growth Rate (2015-2020)
Figure Global Recombinant Glycosylated Protein Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Recombinant Glycosylated Protein Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Recombinant Glycosylated Protein Price and Trend Forecast (2020-2025)
Table Global Recombinant Glycosylated Protein Sales (K Units) Forecast by Region (2020-2025)
Figure Global Recombinant Glycosylated Protein Production Market Share Forecast by Region (2020-2025)
Figure North America Recombinant Glycosylated Protein Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Recombinant Glycosylated Protein Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Recombinant Glycosylated Protein Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Recombinant Glycosylated Protein Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Recombinant Glycosylated Protein Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Recombinant Glycosylated Protein Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Recombinant Glycosylated Protein Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Recombinant Glycosylated Protein Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Novartis International AG Company Profile
Figure Recombinant Glycosylated Protein Product Picture and Specifications of Novartis International AG
Table Recombinant Glycosylated Protein Production, Price, Revenue and Gross Margin of 2018-2020
Figure Novartis International AG Recombinant Glycosylated Protein Market Share (2018-2020)
Table Novartis International AG Main Business
Table Novartis International AG Recent Development
Table Biocon Limited Company Profile
Figure Recombinant Glycosylated Protein Product Picture and Specifications of Biocon Limited
Table Recombinant Glycosylated Protein Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biocon Limited Recombinant Glycosylated Protein Market Share (2018-2020)
Table Biocon Limited Main Business
Table Biocon Limited Recent Development
Table Hospira Inc Company Profile
Figure Recombinant Glycosylated Protein Product Picture and Specifications of Hospira Inc
Table Recombinant Glycosylated Protein Production, Price, Revenue and Gross Margin of 2018-2020
Figure Hospira Inc Recombinant Glycosylated Protein Market Share (2018-2020)
Table Hospira Inc Main Business
Table Hospira Inc Recent Development
Table Celltrion Pharma Inc Company Profile
Figure Recombinant Glycosylated Protein Product Picture and Specifications of Celltrion Pharma Inc
Table Recombinant Glycosylated Protein Production, Price, Revenue and Gross Margin of 2018-2020
Figure Celltrion Pharma Inc Recombinant Glycosylated Protein Market Share (2018-2020)
Table Celltrion Pharma Inc Main Business
Table Celltrion Pharma Inc Recent Development
Table Teva Pharmaceutical Industries Ltd Company Profile
Figure Recombinant Glycosylated Protein Product Picture and Specifications of Teva Pharmaceutical Industries Ltd
Table Recombinant Glycosylated Protein Production, Price, Revenue and Gross Margin of 2018-2020
Figure Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Market Share (2018-2020)
Table Teva Pharmaceutical Industries Ltd Main Business
Table Teva Pharmaceutical Industries Ltd Recent Development
Table of Appendix